The Pharmacy and Poisons Board Explained: How Kenya Regulates Medicine Importation, Manufacturing, Pharmacy Premises and the Pharmacist Profession

The Pharmacy and Poisons Board (PPB) is the principal regulator of medicines, pharmacy premises, and the pharmacist profession in Kenya. Established under the Pharmacy and Poisons Act, Cap 244 of the Laws of Kenya and operating from headquarters at Lenana Road in Nairobi, PPB regulates every aspect of the pharmaceutical value chain from medicine manufacture, import, distribution, and dispensing to the licensing of pharmacy premises (retail pharmacies, wholesale distributors, manufacturing plants) and the registration of pharmacists, pharmaceutical technologists, and the broader pharmacy workforce. The Board's mandate covers the regulation of human medicines, veterinary medicines (in coordination with the Kenya Veterinary Board for veterinary professionals), medical devices (in coordination with the relevant standards), and the broader poisons regulation under the Act. For pharmacists entering the profession, businesses operating pharmacies and wholesale operations, manufacturers producing medicines in Kenya, and importers bringing medicines into the country, the PPB framework is the foundational regulatory environment. This guide walks through the legal framework, the principal licensing categories, the medicine registration process, the pharmacy premises licensing, the pharmaceutical workforce registration, and the practical considerations for participants in the sector.

The Legal Framework

The Pharmacy and Poisons Act, Cap 244 is the master statute. Subsidiary regulations include the Pharmacy and Poisons (Pharmacy Practice) Regulations, the Pharmacy and Poisons (Registration of Drugs) Regulations, and several specialised regulations. The Health Act, 2017 and the broader healthcare statutory framework intersect with the PPB regime. PPB is governed by a Board of Directors that includes pharmacy professionals, public-health representatives, and consumer representatives. The Registrar of the Board leads the executive arm.

Medicine Registration

Every medicine sold or distributed in Kenya must be registered with PPB. The registration covers both originator medicines and generics, both human and veterinary medicines, and both prescription-only and over-the-counter products. Registration requires submission of a Common Technical Document (CTD) covering: quality (manufacturing process, specifications, stability data); safety (preclinical and clinical safety data); and efficacy (clinical efficacy data). Generic medicines additionally require bioequivalence data demonstrating equivalent absorption and effect compared to the originator product. The registration process typically takes 12-24 months for novel medicines and a shorter period for well-established generics. Once registered, the medicine is added to the PPB's Register of Pharmaceutical Products and is permitted for sale in Kenya.

Manufacturing Licensing

Manufacturers producing medicines in Kenya require a manufacturing licence from PPB. The licence covers the manufacturing facility, the production processes, the quality management system, the trained workforce, and the broader operational arrangements. Good Manufacturing Practice (GMP) inspection by PPB is conducted at initial licensing and on a periodic basis throughout the licence life. Manufacturing licences are issued for specific product categories and dosage forms; expansion into additional categories requires variation of the licence with additional inspection.

Importer and Wholesale Distributor Licensing

Companies importing or wholesaling medicines in Kenya require a wholesale dealer's licence from PPB. The licence covers: storage facilities meeting the prescribed temperature and security standards; a Responsible Pharmacist appointed to supervise the operations; the quality management system covering receipt, storage, dispatch, and traceability; and the cold-chain arrangements for medicines requiring temperature control. PPB inspects wholesale facilities at initial licensing and periodically thereafter.

Retail Pharmacy Premises Licensing

Retail pharmacies — community pharmacies, hospital pharmacies, and dispensaries — require premises licensing from PPB. Requirements include: a registered pharmacist or pharmaceutical technologist appointed to supervise the premises; the physical premises meeting prescribed layout, dispensing area, and storage standards; the appropriate dispensing equipment and reference materials; the medicines stock from licensed sources only; and the broader operational compliance with the dispensing standards. PPB inspections at the premises level are conducted at initial licensing and on a periodic basis, with non-compliance producing conditional licensing or suspension.

The Pharmacist Profession

Pharmacists in Kenya register with PPB after completing the Bachelor of Pharmacy degree at the University of Nairobi, Kenyatta University, JKUAT, Mount Kenya University, or other accredited Kenyan institution, completing the prescribed internship period under a registered preceptor pharmacist, and passing the Pharmacy Council Final Examination. Pharmaceutical technologists register separately after completing the Diploma in Pharmacy at one of the accredited training institutions. Both categories of pharmacy worker hold annual practice licences renewed each year subject to CPD compliance.

The Substandard and Falsified Medicines Challenge

The presence of substandard and falsified medicines in Kenyan markets is one of the most significant patient-safety challenges PPB addresses. The Authority's market surveillance programme, the laboratory testing capacity at the National Quality Control Laboratory, and the cooperation with the Anti-Counterfeit Authority and the Kenya Revenue Authority Customs handle the enforcement against these products. Patients should buy medicines only from licensed pharmacies; suspicious-looking medicines (incorrect packaging, unusual labelling, abnormal physical appearance) should be reported to PPB through the pharmacovigilance reporting system.

Pharmacovigilance

PPB operates the National Pharmacovigilance Programme that monitors adverse drug reactions and product quality concerns. Healthcare professionals, pharmacists, and patients can report suspected adverse drug reactions through the PPB's online reporting system. The Authority analyses the reports, identifies patterns suggesting drug safety concerns, and takes regulatory action where required including label updates, prescribing restrictions, market withdrawals, and broader safety advisories.

Drug Pricing and Affordability

PPB's regulatory remit does not include direct price regulation of medicines; pricing is left to commercial dynamics under the broader competition framework. The Authority cooperates with the Ministry of Health and the Social Health Authority on the broader medicine-access and affordability agenda, particularly for the essential medicines list and for the products covered under the SHA medical benefit scheme.

Practical Considerations

For pharmacists entering the profession: complete the academic and internship requirements thoroughly; maintain annual practice licence currency through CPD; engage with the Pharmaceutical Society of Kenya as the professional body. For pharmacy business owners: engage PPB pre-application on premises selection and design; appoint a credible Responsible Pharmacist; comply with stock-source requirements (only licensed wholesalers); maintain accurate dispensing records. For pharmaceutical importers and wholesalers: secure the wholesale dealer's licence with adequate storage and cold-chain infrastructure; appoint a credible Responsible Pharmacist; comply with traceability requirements. For patients and consumers: buy medicines only from licensed pharmacies; ask for receipts and retain them; report any suspected substandard product to PPB.

The Bigger Picture

Medicines are among the most consequential consumer products — directly affecting health outcomes, vulnerable populations, and the broader healthcare-system effectiveness. The PPB regulatory framework is the institutional response to ensuring that medicines sold in Kenya are safe, effective, and of acceptable quality. The framework operates alongside the broader healthcare regulatory environment of KMPDC, the Kenya Nursing Council, the Health Records and Information Managers Board, the Kenya Veterinary Board, and the broader Ministry of Health framework. For all participants in the sector — pharmacists, manufacturers, importers, distributors, retailers, and patients — mastering the PPB framework is foundational.

The Pharmacy and Poisons Board publishes the registration forms, the Register of Pharmaceutical Products, the licensed premises list, and the regulatory framework documents.